Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D4DK2R
|
|||
| Drug Name |
DBI-001
|
|||
| Indication | Tinea pedis [ICD-11: 1F28.2; ICD-10: B35.3] | Phase 2 | [1] | |
| Company |
DermBiont
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04152226) Open Label, Single-dose, Dose Escalating Evaluation of the Safety and Tolerability of DBI-001 in Patients With T. Pedis. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.